Dr. Rupesh Kotecha: September 8, 2020

FIRST FDA-APPROVED TREATMENT OPTION FOR MESOTHELIOMA IN OVER 15 YEARS

Learn the facts about mesothelioma and how a technology already approved for brain cancer is offering an innovative option for treatment

*** September 26th is Mesothelioma Awareness Day ***

 

 

Dr. Rupesh Kotecha (pron. ko-tay-cha),

Radiation Oncologist at Miami Cancer Institute

 

 

Each year, an estimated 3,000 Americans are diagnosed with mesothelioma, a rare type of cancer that forms in the lining of major organs in the chest or stomach. Over 70% of people diagnosed with mesothelioma have been exposed to asbestos, making it the leading cause of the disease.

 

The most common form is malignant pleural mesothelioma (MPM), but less than 30% of patients were candidates for surgery to remove the tumor, according to a SEER-Medicare data set analysis in elderly MPM patients, opening the door for new and innovative treatments. In 2019, the FDA approved a new treatment for MPM called Optune Lua, which is the first treatment approved by the FDA for the disease in more than 15 years. Optune Lua is a wearable and portable cancer treatment that delivers Tumor Treating Fields (TTFields) to the region of the tumor. TTFields are low-intensity alternating electric fields tuned to specific frequencies that continuously disrupt cancer cell division.

 

Optune Lua for MPM is classified as a Humanitarian Use Device (HUD), approved under the Humanitarian Device Exemption (HDE). The HDE pathway was created to encourage companies to innovate in rare diseases with underserved patient populations.

 

On Tuesday, September 8, 2020, in advance of Mesothelioma Awareness Day, Dr. Rupesh Kotecha, will be available for interviews. He will discuss the history of MPM, who is at risk, the symptoms to look for and this innovative treatment option.

 

About Malignant Pleural Mesothelioma (MPM)

Malignant pleural mesothelioma is a rare thoracic solid tumor cancer that has been strongly linked to asbestos exposure. Malignant pleural mesothelioma causes symptoms, such as chest pain and shortness of breath, that are frustratingly similar to those of more common illnesses. There are approximately 3,000 new cases of mesothelioma annually in the United States.

 

 

 

For more information, please visit: learnaboutmeso.com

 

Speak Your Mind

*